Genes for Alzheimer Dementia

Area of Science:

• Neurology
• Geriatrics
• Genetics

Background:

• Alzheimer disease (AD) is the most prevalent form of dementia in the elderly.
• The increasing elderly population in developed nations exacerbates the AD health problem.
• Currently, no effective therapies exist for Alzheimer disease.

Purpose of the Study:

• To summarize the current understanding of Alzheimer disease diagnosis and contributing factors.
• To highlight the diagnostic criteria and pathological hallmarks of AD.
• To underscore the significance of both age and genetic factors in AD development.

Main Methods:

• Clinical diagnosis relies on neurological examination, neuropsychological testing, and brain imaging.
• Definitive diagnosis is confirmed post-mortem by identifying senile plaques (SPs) and neurofibrillary tangles (NFTs).
• Pathological hallmarks include extracellular amyloid P deposits (SPs) and intraneural paired helical filaments of hyperphosphorylated tau (NFTs).

Main Results:

• Clinical diagnostic reliability reaches 90% using current methods.
• Post-mortem analysis reveals SPs and NFTs as definitive markers for Alzheimer disease.
• Population and family studies indicate substantial genetic contributions to AD expression.

Conclusions:

• Alzheimer disease presents a significant and growing challenge in aging populations.
• Accurate diagnosis involves clinical assessment and definitive post-mortem pathological confirmation.
• Both advanced age and genetic predisposition are key factors in the development of Alzheimer disease.